RARE
Ultragenyx Pharmaceutical Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #720
- Final score
- 40.20
- Years on list
- 4
↗ Climbed 130 since 2022
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- RARE· Ultragenyx Pharmaceutical Inc.
- TECH· Bio-Techne Corporation
- INSM· Insmed Incorporated
Figure 01 · Side-by-side summary
The headline numbers
TECH
Bio-Techne CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #685
- Final score
- 42.06
- Years on list
- 6
↗ Climbed 55 since 2020
INSM
Insmed IncorporatedPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #759
- Final score
- 37.18
- Years on list
- 1
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | RARE | TECH | INSM |
|---|---|---|---|
| Climate Change | 26.8 | 38.1 | 38.9 |
| Employee Relations | 45.1 | 45.0 | 41.6 |
| Environment | 30.1 | 40.1 | 36.2 |
| Stakeholders & Society | 56.9 | 53.6 | 28.2 |
| Human Rights | 50.8 | 32.7 | 37.9 |
| Governance | 38.4 | 40.2 | 34.3 |
| Performance Rating | 51.8 | 46.9 | 44.8 |